
### [NCIT:C84270](http://purl.obolibrary.org/obo/NCIT_C84270)
**Label:** Myeloid and Lymphoid Neoplasms with Eosinophilia and Rearrangement of PDGFRA, PDGFRB, or FGFR1, or with PCM1-JAK2

**Subclasses:** [NCIT:C84275](http://purl.obolibrary.org/obo/NCIT_C84275) (Myeloid and Lymphoid Neoplasms with PDGFRA Rearrangement), [NCIT:C84277](http://purl.obolibrary.org/obo/NCIT_C84277) (Myeloid and Lymphoid Neoplasms with FGFR1 Rearrangement), [NCIT:C84276](http://purl.obolibrary.org/obo/NCIT_C84276) (Myeloid and Lymphoid Neoplasms with PDGFRB Rearrangement), [NCIT:C129852](http://purl.obolibrary.org/obo/NCIT_C129852) (Chronic Myelomonocytic Leukemia with Eosinophilia Associated with t(5;12)(q31;p12)), [NCIT:C126351](http://purl.obolibrary.org/obo/NCIT_C126351) (Chronic Eosinophilic Leukemia with FIP1L1-PDGFRA), 

**Class expressions from DL-Learner:**

- Thing 51.79%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) 45.36%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40284](http://purl.obolibrary.org/obo/NCIT_C40284) (Vulvar Keratinizing Squamous Cell Carcinoma))) 45.36%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40275](http://purl.obolibrary.org/obo/NCIT_C40275) (Benign Vaginal Mixed Epithelial and Mesenchymal Neoplasm))) 45.36%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40272](http://purl.obolibrary.org/obo/NCIT_C40272) (Vaginal Undifferentiated Sarcoma))) 45.36%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40271](http://purl.obolibrary.org/obo/NCIT_C40271) (Low Grade Endometrioid Stromal Sarcoma of the Vagina))) 45.36%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C4027](http://purl.obolibrary.org/obo/NCIT_C4027) (Paget Disease of the Vulva))) 45.36%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40264](http://purl.obolibrary.org/obo/NCIT_C40264) (Vaginal Undifferentiated Carcinoma))) 45.36%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40263](http://purl.obolibrary.org/obo/NCIT_C40263) (Vaginal Small Cell Carcinoma))) 45.36%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40261](http://purl.obolibrary.org/obo/NCIT_C40261) (Vaginal Adenoid Cystic Carcinoma))) 45.36%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40260](http://purl.obolibrary.org/obo/NCIT_C40260) (Vaginal Adenosquamous Carcinoma))) 45.36%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C4026](http://purl.obolibrary.org/obo/NCIT_C4026) (Ovarian Mucinous Cystadenocarcinoma))) 45.36%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40259](http://purl.obolibrary.org/obo/NCIT_C40259) (Vaginal Villous Adenoma))) 45.36%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40258](http://purl.obolibrary.org/obo/NCIT_C40258) (Vaginal Tubulovillous Adenoma))) 45.36%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40257](http://purl.obolibrary.org/obo/NCIT_C40257) (Vaginal Tubular Adenoma))) 45.36%


